To determine whether psychiatrically stable patients with a history of drug-induced psychosis could be successfully weaned off their antipsychotic drug, we offered consecutive Parkinson disease (PD) patients on quetiapine or clozapine, who were free of any on-going psychosis, to be slowly weaned off their antipsychotic drug. Before the study was aborted 6 PD patients (mean age, 78 years) with an average antipsychotic exposure of 20 months (5 on quetiapine, 1 on clozapine) were enrolled. After the antipsychotic agent was discontinued, psychosis recurred in 5 of 6 patients. In 3 patients the "rebound psychosis" was worse than the original psychotic episode and required subsequent higher antipsychotic medication doses.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/mds.20260 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Olanzapine during lactation: impact on testicular morphometry and endocrine parameters in adult wistar rats.
An Acad Bras Cienc
August 2024
Universidade Federal Rural de Pernambuco/UFRPE, Departamento de Medicina Veterinária, Rua Dom Manuel de Medeiros, s/n, Dois Irmãos, 52171-900 Recife, PE, Brazil.
Article Synopsis
- Olanzapine (OLZ) is an antipsychotic used for postpartum psychiatric symptoms and its effects on lactating rats were studied regarding adult male offspring's testicular health.
- Higher doses of OLZ (5 and 10 mg/kg) led to significant decreases in body and testicular weight, along with reduced testicular structure and function in adult Wistar rats.
- The study found that the highest doses of OLZ caused adverse testicular changes, including degeneration and lower testosterone levels, while a dose of 2.5 mg/kg was noted as relatively safer.
SEP-363856 exerts neuroprotection through the PI3K/AKT/GSK-3β signaling pathway in a dual-hit neurodevelopmental model of schizophrenia-like mice.
Drug Dev Res
June 2024
Department of Psychiatry, Chaohu Hospital of Anhui Medical University, Hefei, Anhui, China.
Article Synopsis
- Schizophrenia (SZ) is a serious neurodevelopmental disorder primarily treated with antipsychotics, and SEP-363856 is a new antipsychotic currently being studied that doesn't act on dopamine D receptors, but its mechanism is still unclear.
- The study involved creating an animal model of SZ using perinatal MK-801 treatment combined with social isolation, and various behavioral tests and molecular analyses were performed to assess the effects of SEP-856.
- Results showed that SEP-856 significantly improved symptoms in the SZ-like model by reducing hyperactivity, enhancing social interaction, and reversing other SZ-associated behaviors.
A 45-year-old man on public welfare, who had been visiting a psychiatric hospital for schizoaffective disorder, began working as a package delivery person for the first time in the morning after receiving welfare. In the afternoon, he noticed pain in his lower back. By evening, he was unable to move, prompting an emergency call and transportation to our hospital.
View Article and Find Full Text PDFKey Clinical Message: COVID-19 psychosis is a potential long-term sequela of COVID-19. Vulnerable populations, such as individuals with sickle cell disease, are at high risk for psychosis. Given the limited number of cases, more investigations in the etiopathology and management of this new disease is needed.
View Article and Find Full Text PDFPhenibut: Review and Pharmacologic Approaches to Treating Withdrawal.
J Clin Pharmacol
June 2024
Department of Pharmacy Practice, Harrison College of Pharmacy, Auburn University, Auburn, AL, USA.
β-Phenyl-γ-aminobutyric acid (phenibut) is an analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) that was first synthesized in Russia in the early 1960s. It is marketed as a nootropic (smart drug) to improve cognitive performance, and to treat generalized and social anxiety, insomnia, and alcohol withdrawal. The use of phenibut is legal in the USA and it is widely available online without a prescription.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!